Experimental procedures 3 4
In vitro CNN3 phosphorylation assay 22 rCNN3 (10 μg) was phosphorylated in vitro with either 100 ng ROCKII active (Millipore) or 50 23 ng casein kinase1 active (Millipore) in an assay solution (50 μl) containing 50 mM Tris-HCl pH 24 7.5, 2 mM EGTA, 1 mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 6 mM KCl, 10 mM MnCl 2 and 100 25 μM ATP. Reaction was terminated by addition of SDS-PAGE sample buffer. Phosphorylated 26 rCNN3 was visualized by either ProQ Diamond phospho-specific staining or Western blotting 27 using antibodies raised against phosphorylated S293 of CNN3. 28
29
In-gel digestion and peptide mass fingerprinting 30 The gel pieces were washed twice in 300 μl of CH 3 CN for 30 min and dried. The gel pieces 31 were then rehydrated in 100 μl of reduction buffer (10 mM DTT and 100 mM NH 4 HCO 3 ) and 32 left standing at 56ºC for 1 h. After removal of supernatant, the gel pieces were incubated in 33 100 μl of 50 mM iodoacetamide in 100 mM NH 4 HCO 3 at room temperature for 45 min. The 34 gel pieces were then washed in 100 μl of 100 mM NH 4 HCO 3 and dehydrated in 300 μl of 35 CH 3 CN. After washing and dehydration, the dried gel pieces were rehydrated on ice in 36 digestion buffer containing 50 mM Tris-HCl pH 8.0, 10 ng/μl each of lysylendopeptidase 1 (WAKO, Osaka, Japan) and modified trypsin (Promega) for 45 min. The supernatant was 2 replaced with 10 μl of 50 mM Tris-HCl, pH 8.0, and the gel pieces were incubated at 37ºC 3 overnight. The supernatant was collected and the digested peptides were extracted repeatedly 4 with a 50 μl solution of 5% (v/v) formic acid and 50% (v/v) CH 3 CN by vortexing. The 5 combined supernatant was evaporated to dryness in a vacuum centrifuge. Resulting peptides 6 were absorbed onto a ZipTip C18 (Millipore), and bound peptides were eluted with 50% 7 CH 3 CN and 0.1% trifluoroacetic acid (TFA). Equal amounts of the resulting peptide solution 8 and a sample matrix (saturated α-cyano-4-hydroxycinnamic acid dissolved in 50% CH 3 CN and 9 0.1% TFA) for matrix-assisted laser desorption/ionization (MALDI) were mixed on the sample 10 target for mass spectrometry (MS). Peptide mass fingerprinting was carried out with Mascot 11 search for the peptide masses obtained by a Voyager DE-Pro time-of-flight mass spectrometer 12 (Applied Biosystems). 13 14
Phospho-peptide enrichment and MS 15
Purified FlagCNN3 was reduced with DTT followed by carbamidomethylation, and the 16 alkylated samples were digested with a mixture of trypsin and lysylendopeptidase in a buffer 17 containing 0.1 M Tris HCl (pH 8.0) at 37ºC overnight. Phosphopeptides from the digests were 18 enriched using a MonoTip TiO (Larsen et al., 2005; Liang et al., 2006; Thingholm et al., 2006; 19 Sugiyama et al., 2007) (GL Science, Tokyo, Japan) according to the manufacturer's protocol. 20 Dephosphorylation reactions were performed in 50 mM NH 4 HCO 3 containing 0.1% alkaline 21 phosphatase at 37ºC for 15 min. Alternatively, to collect the phosphopeptides, HPLC of the 22 digests was carried out on a C18 column (150 × 1.0 mm) with a linear gradient elution of 23
The phosphopeptides isolated by HPLC or MonoTip 24
TiO were subjected to MS or further digested with endoproteinase AspN (Roche Diagnostics, 25 Basel, Switzerland) in a buffer containing 50mM Tris-HCl at pH 7.4, and then dried for MS. 26 The measurements for phosphopeptides were carried out in linear TOF mode. Tandem mass 27 spectrometry (MS/MS) was performed on a MALDI multiple-stage tandem mass spectrometer 28 AXIMA-QIT (Shimadzu, Kyoto, Japan). was transduced using a lentivirus and the HEK293 cells were treated with 50 μM forskolin for 9 the indicated times. Flag-CNN3 was recovered by immunoprecipitation using anti-FLAG 10 agarose and co-IP assay was carried out using the indicated antibodies. (E) EYFP-CNN3 11 distribution was not changed by forskolin treatment in HEK293 cells alone. Scale bar: 50 μm. 12 (F) Wild type (WT) or ΔC Flag-CNN3 expressing HEK293 cells were treated with forskolin for 13 the indicated times and CNN3-actin association was analyzed by co-IP assay using anti-Flag 14 agarose. (G) In vitro-phosphorylation assay was performed using rCNN3 as substrate. probed with various dilutions of normal rabbit serum (■), antibodies which were 9 affinity-purified using phospho-peptide-conjugated sepharose and pre-absorbed with ( ▲) or 10 absorbed (
•) with non -phospho peptide-conjugated sepharose and an non-phospho 11 peptide-adsorbed fraction (x). Note that phospho-S293 antibody has no reactivity with 12 non-phospho peptide but that of phospho-S296 antibody remained weakly. (E) FlagCNN3s 13
were transiently transfected to HEK293 cells by calcium phosphate. Equal amount of TCL 14 samples were subjected to SDS-PAGE and analysed by western blotting using indicated 15
antibodies. The antibody against phospho-S293 works well, but that against phospho-S296 16 has residual affinity to non-phosphorylated CNN3 peptide as shown in D ( ▲) and displays 17 non-specific binding to the overexpressed CNN3. (F) BeWo TCL samples were prepared with 18 or without forskolin treatment for indicated times and analyzed by western blotting using 19 indicated antibodies. Since the specificity of the antibody raised against phospho-S296 was 20 poor, this antibody was applied to the cytosolic fraction in Figure 6A . 
